96920

Laser treatment for inflammatory skin disease (psoriasis); total area less than 250 sq cm

CPT code 96920 represents a highly targeted, localized dermatological procedure involving the application of an excimer laser for the treatment of inflammatory skin diseases, with a specific focus on psoriasis, covering a total anatomical surface area of less than 250 square centimeters. Psoriasis is a chronic, immune-mediated inflammatory skin condition characterized by hyperproliferation of keratinocytes and the formation of erythematous, scaly plaques. Traditional broad-band or narrow-band ultraviolet B (UVB) phototherapy exposes the entire body or large segments of healthy skin to ultraviolet radiation, which can increase the risk of photoaging and phototoxicity. In contrast, the excimer laser, which typically operates at a wavelength of 308 nanometers, delivers highly concentrated, monochromatic UVB light exclusively to the affected psoriatic plaques. By utilizing a fiber-optic handpiece, the physician or qualified healthcare professional can precisely target the lesions while entirely sparing the surrounding unaffected skin. This precision allows for the administration of higher cumulative doses of therapeutic UVB radiation directly to the pathology, which accelerates the clearance of plaques and significantly reduces the total number of treatment sessions required to achieve clinical remission. The targeted approach also minimizes the risk of systemic side effects commonly associated with oral immunosuppressants or biologic agents, making it an excellent localized therapy for patients with mild to moderate disease, or those with recalcitrant plaques in challenging anatomical locations such as the elbows, knees, scalp, or palms. The clinical encounter begins with a thorough evaluation of the patient's skin, calculation of the affected body surface area to ensure it falls strictly below the 250 square centimeter threshold, and determination of the appropriate laser dosimetry based on the patient's Fitzpatrick skin type and plaque thickness. The physician systematically directs the laser handpiece over each plaque, delivering precisely calibrated pulses of light. After the intervention, the patient is monitored for immediate adverse reactions such as blistering or excessive erythema. Documentation must explicitly state the total surface area treated to support the selection of 96920 over higher-tier codes like 96921 or 96922.

Clinical Indications

  • Mild to moderate plaque psoriasis localized to areas less than 250 square centimeters.
  • Recalcitrant psoriatic plaques that have failed to respond to topical corticosteroids, vitamin D analogues, or other topical therapies.
  • Psoriasis located in cosmetically sensitive or difficult-to-treat areas such as the scalp, elbows, knees, palms, and soles.
  • Patients with localized inflammatory skin diseases for whom systemic therapies or biologic agents are contraindicated or undesired.
  • Targeted phototherapy for other inflammatory skin conditions (such as severe localized eczema or vitiligo) when supported by payer-specific coverage policies, though the primary CPT description specifies psoriasis.

Procedure Steps

  1. Review the patient's medical history, prior phototherapy treatments, and current medications to rule out photosensitizing drugs.
  2. Conduct a physical examination of the skin to identify and measure all active psoriatic plaques intended for treatment.
  3. Calculate the total combined surface area of the targeted lesions to verify it is strictly less than 250 square centimeters.
  4. Determine the appropriate laser dosimetry (measured in millijoules per square centimeter) based on the patient's Fitzpatrick skin phototype, anatomical location of the plaques, and the thickness of the lesions.
  5. Provide the patient and all personnel in the room with appropriate UV-protective eyewear.
  6. Activate the 308-nm excimer laser and place the fiber-optic handpiece directly over or slightly above the targeted psoriatic plaque.
  7. Deliver the calculated dose of UVB light to the lesion, moving the handpiece systematically to cover the entire plaque without overlapping excessively or exposing adjacent healthy skin.
  8. Repeat the process for all identified lesions until the total indicated area has been treated.
  9. Apply soothing emollients or topical corticosteroids post-treatment if indicated, and instruct the patient on post-procedure care, including sun protection and monitoring for erythema or blistering.
  10. Document the exact anatomical locations, the cumulative surface area treated, the dosimetry used, and the patient's tolerance of the procedure in the medical record.

Coding Guidelines

  • CPT 96920 is strictly for a total treated area of less than 250 sq cm. Measure and clearly document the exact total surface area in the clinical note to justify the code selection.
  • Do not report 96920 in conjunction with 96921 (250-500 sq cm) or 96922 (over 500 sq cm) for the same date of service. Select only one code based on the total combined area treated.
  • This code should not be reported with general phototherapy codes (e.g., 96900, 96910, 96912) if the treatments are performed on the same anatomical area. If performed on different anatomical areas, appropriate modifiers (e.g., modifier 59 or XS) may be required depending on payer policies.
  • Evaluation and Management (E/M) services should generally not be reported on the same day as 96920 unless there is a significant, separately identifiable E/M service provided, which would require a modifier 25.
  • Ensure the diagnosis code specifically reflects the inflammatory skin condition being treated (e.g., L40.0 for plaque psoriasis) as payer coverage policies often restrict 96920 to specific ICD-10 codes.

Associated ICD-10 Codes